Namur Thrombosis and Hemostasis Center

Research output

Research output per year 1989 2014 2015 2016 2017 2018 2019 2021 2023 2024

• 5572 Citations
• 39 h-index
• 160 Article
• 158 Poster
• 55 Conference contribution
• 32 Review article
• 39 More
  • 11 Letter
  • 6 Chapter
  • 6 Literature review
  • 3 Comment/debate
  • 3 Editorial
  • 2 Meeting abstract
  • 2 Short survey
  • 2 Patent
  • 1 Commissioned report
  • 1 Other
  • 1 Special issue
  • 1 Master's Thesis

Research output per year

Research output per year

Search results

• BM 34, an anticonvulsivant sulfonylurea with a phenytoin-like profile

  Masereel, B., Lambert, D. M., Dogne, J-M., de Tullio, P., Pirotte, B., Pochet, L. & Delarge, J., 1996, In: Journal de Pharmacie de Belgique. 51, (1), p. 115

  Research output: Contribution to journal › Literature review › peer-review

• Discovery and optimization of indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2-3 dioxygenase (IDO), a promising target for anti-cancer immunotherapy.

  Frédérick, R., Blanc, S., Larrieu, P., Moineaux, L., Colette, D., Fraser, G., Stroobant, V., Pilotte, L., Colaux, D., Wouters, J., Masereel, B., Van den Eynde, B. & Dolušić, E., 2010, In: Drugs of the future. 35, suppl A, p. 181-182

  Research output: Contribution to journal › Literature review › peer-review

• Inhibition study of monoamine oxidases by ß-carboline derivatives.

  Reniers, J., Robert, S., Frédérick, R., Masereel, B., Vincent, S. & Wouters, J., 2010, In: Drugs of the future. 35, suppl A, p. 189

  Research output: Contribution to journal › Literature review › peer-review

• Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Design, Synthesis and Preclinical Evaluation of a Novel TDO Inhibitor.

  Dolušić, E., Larrieu, P., Moineaux, L., Stroobant, V., Pilotte, L., Colaux, D., Van den Eynde, B., Masereel, B., Wouters, J. & Frédérick, R., 2012, In: ChemMedChem. p. 371 1 p.

  Research output: Contribution to journal › Literature review › peer-review

• Structural and enzymatic study of tryptophan 2,3-dioxgenase (TDO), a potential target in anticancer immunotherapy.

  Moineaux, L., Charlier, C., Dolušić, E., Larrieu, P., Pilotte, L., Colaux, D., Stroobant, V., Galleni, M., Masereel, B., Van den Eynde, B., Wouters, J. & Frédérick, R., 2010, In: Drugs of the future. 35, suppl A, p. 189

  Research output: Contribution to journal › Literature review › peer-review

• Substitution of 2-carbonyl in phenytoin ans its consequences on the pharmacological efficacy and pharmacokinetics

  Lambert, D. M., Masereel, B., Gallez, B., Geurts, M., Poupaert, J. & Scriba, G. K. E., 1997, In: Journal de Pharmacie de Belgique. 52, (2b), p. 32

  Research output: Contribution to journal › Literature review › peer-review